Clinical applications of cardiovascular angiogenesis

Journal of Cardiac Surgery

Volumn 16, Issue 6, 2001, Pages 490-497

  Zimmerman, Michael A ^a   Selzman, Craig H ^a   Raeburn, Christopher D ^a   Calkins, Casey M ^a   Barsness, Katherine ^a   Harken, Alden H ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; COMPLEMENTARY DNA; DNA; PLASMID DNA; RECOMBINANT PROTEIN; VASCULOTROPIN;

ANGIOGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL OCCLUSION; CANCER; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; SURVIVAL; VASCULAR SMOOTH MUSCLE; WOUND HEALING;

EID: 0035573438     PISSN: 08860440     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8191.2001.tb00555.x     Document Type: Conference Paper

References (49)

1. Tumor behavior in isolated perfused organs: In vitro growth and metastases of biopsy material in rabbit thyroid and canine intestinal segment
2. Surgical implications of therapeutic angiogenesis
3. Neutrophils and mononuclear cells express vascular endothelial growth factor in acute Kawasaki disease: Its possible role in progression of coronary artery lesions
4. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers
5. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma
6. Angiogenesis in human coronary atherosclerotic plaques
7. Angiogenesis and the atherosclerotic carotid plaque: An association between symptomatology and plaque morphology
8. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina
9. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor
10. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury
11. Induction of neoangiogenesis in ischemic myocardium by human growth factors: First clinical results of a new treatment of coronary heart disease
12. Angiogenesis in ischemic human myocardium: Clinical results after 3 years
13. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: Results of a phase 1 randomized, double-blind, placebo-controlled trial
14. Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris
15. Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: Results of a Phase I open-label dose escalation study
16. Results from late-breaking clinical trials sessions at ACCIS 2000 and ACC 2000
17. Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia
18. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease
19. Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia
20. Angiogenesis gene therapy: Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease
21. Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: Evidence for a dose-dependent effect
22. VIVA trial: One-year follow-up
23. Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo
24. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo
25. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia
26. Fibroblast growth factor as therapy for critical limb ischemia: A case report
27. Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor
28. Basic fibroblast growth factor in patients with intermittent claudication: Results of a phase I trial
29. Immunohistochemical study of intimal microvessels in coronary atherosclerosis
30. Vasa vasorum in atherosclerotic coronary arteries: Responses to vasoactive stimuli and regression of atherosclerosis
31. Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia
32. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries
33. Expression of basic and acidic fibroblast growth factors and their receptor in normal and atherosclerotic human arteries
34. The NFkappaB inhibitory peptide, IkappaBalpha, prevents human vascular smooth muscle proliferation
35. Adenovirus-mediated expression of the secreted form of basic fibroblast growth factor (FGF-2) induces cellular proliferation and angiogenesis in vivo
36. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: Possible pathophysiological significance of VEGF in progression of atherosclerosis
37. Activated macrophages induce vascular proliferation
38. Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery
39. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice
40. Neovascularization in atherectomy specimens from patients with unstable angina: Implications for pathogenesis of unstable angina
41. Vascular endothelial growth factor enhances atherosclerotic plaque progression
42. Local delivery of vascurar endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery
43. Passivation of metallic stents after arterial gene transfer of phVEGF165 inhibits thrombus formation and intimal thickening
44. Cancer and atherosclerosis: The broad mandate of angiogenesis
45. Angiogenesis and atherosclerosis. The mandate broadens
46. Preclinical and clinical studies with recombinant human basic fibroblast growth factor
47. Hypotensive activity of fibroblast growth factor
48. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy
49. Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects